Jun Kanazawa1, Hironori Masuko2, Yohei Yatagai1, Tohru Sakamoto1, Hideyasu Yamada1, Yoshiko Kaneko1, Haruna Kitazawa1, Hiroaki Iijima3, Takashi Naito3, Takefumi Saito4, Emiko Noguchi5, Satoshi Konno6, Masaharu Nishimura6, Tomomitsu Hirota7, Mayumi Tamari7, Nobuyuki Hizawa1. 1. Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan. 2. Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan. Electronic address: hmasuko@md.tsukuba.ac.jp. 3. Tsukuba Medical Center, Tsukuba, Japan. 4. National Hospital Organization, Ibarakihigashi National Hospital, Tokai, Japan. 5. Department of Medical Genetics, University of Tsukuba, Tsukuba, Japan. 6. First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan. 7. Laboratory for Respiratory and Allergic Diseases, Center for Integrative Medical Sciences, Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan.
Abstract
BACKGROUND: Recent studies have demonstrated that a coding SNP (rs6967330, Cys529→Tyr) in cadherin-related family member 3 (CDHR3), which was previously associated with wheezing illness and hospitalizations in infancy, could support efficient human rhinovirus C (RV-C) entry and replication. Here, we sought to examine the genetic contribution of this variant to the development of adult asthma. METHODS: We performed a candidate gene case-control association study of 2 independent Japanese populations (a total of 3366 adults). The odds ratios (ORs) for association of the A allele at rs6967330 with adult asthma were calculated according to age at onset of asthma. In addition, the effect of the CDHR3 genotype on the development of specific asthma phenotypes was examined. RESULTS: The A allele was associated with asthma (OR = 1.56; Mantel-Haenszel p = 0.0040) when the analysis was limited to patients with early-onset adult asthma. In addition, when the analysis was limited to atopic individuals, a stronger association of the CDHR3 variant with early-onset asthma was found, and interaction of the CDHR3 genotype with atopy was demonstrated. Finally, a significant association of this variant was specifically found with a phenotype of asthma characterized by atopy, early-onset, and lower lung function. CONCLUSIONS: Our study supports the concept that the CDHR3 variant is an important susceptibility factor for severe adult asthma in individuals who develop the disease in early life. The interaction between the CDHR3 variant and atopy indicates that genetic predisposition to early respiratory viral infection is combined with atopy in promoting asthma.
BACKGROUND: Recent studies have demonstrated that a coding SNP (rs6967330, Cys529→Tyr) in cadherin-related family member 3 (CDHR3), which was previously associated with wheezing illness and hospitalizations in infancy, could support efficient human rhinovirus C (RV-C) entry and replication. Here, we sought to examine the genetic contribution of this variant to the development of adult asthma. METHODS: We performed a candidate gene case-control association study of 2 independent Japanese populations (a total of 3366 adults). The odds ratios (ORs) for association of the A allele at rs6967330 with adult asthma were calculated according to age at onset of asthma. In addition, the effect of the CDHR3 genotype on the development of specific asthma phenotypes was examined. RESULTS: The A allele was associated with asthma (OR = 1.56; Mantel-Haenszel p = 0.0040) when the analysis was limited to patients with early-onset adult asthma. In addition, when the analysis was limited to atopic individuals, a stronger association of the CDHR3 variant with early-onset asthma was found, and interaction of the CDHR3 genotype with atopy was demonstrated. Finally, a significant association of this variant was specifically found with a phenotype of asthma characterized by atopy, early-onset, and lower lung function. CONCLUSIONS: Our study supports the concept that the CDHR3 variant is an important susceptibility factor for severe adult asthma in individuals who develop the disease in early life. The interaction between the CDHR3 variant and atopy indicates that genetic predisposition to early respiratory viral infection is combined with atopy in promoting asthma.
Authors: Jamie L Everman; Satria Sajuthi; Benjamin Saef; Cydney Rios; Ari M Stoner; Mari Numata; Donglei Hu; Celeste Eng; Sam Oh; Jose Rodriguez-Santana; Eszter K Vladar; Dennis R Voelker; Esteban G Burchard; Max A Seibold Journal: J Allergy Clin Immunol Date: 2019-03-29 Impact factor: 10.793
Authors: Mary B O'Neill; Guillaume Laval; João C Teixeira; Ann C Palmenberg; Caitlin S Pepperell Journal: Hum Mol Genet Date: 2020-03-27 Impact factor: 6.150
Authors: Sarmila Basnet; Yury A Bochkov; Rebecca A Brockman-Schneider; Ine Kuipers; Scott W Aesif; Daniel J Jackson; Robert F Lemanske; Carol Ober; Ann C Palmenberg; James E Gern Journal: Am J Respir Cell Mol Biol Date: 2019-10 Impact factor: 6.914
Authors: Anneloes L van Rijn; Sander van Boheemen; Igor Sidorov; Ellen C Carbo; Nikos Pappas; Hailiang Mei; Mariet Feltkamp; Marianne Aanerud; Per Bakke; Eric C J Claas; Tomas M Eagan; Pieter S Hiemstra; Aloys C M Kroes; Jutte J C de Vries Journal: PLoS One Date: 2019-10-24 Impact factor: 3.240
Authors: Scott D Hirsch; Christina L Elling; Tori C Bootpetch; Melissa A Scholes; Lena Hafrén; Sven-Olrik Streubel; Harold S Pine; Todd M Wine; Wasyl Szeremeta; Jeremy D Prager; Elisabet Einarsdottir; Ayesha Yousaf; Erin E Baschal; Sakina Rehman; Michael J Bamshad; Deborah A Nickerson; Saima Riazuddin; Suzanne M Leal; Zubair M Ahmed; Patricia J Yoon; Juha Kere; Kenny H Chan; Petri S Mattila; Norman R Friedman; Tasnee Chonmaitree; Daniel N Frank; Allen F Ryan; Regie Lyn P Santos-Cortez Journal: J Mol Med (Berl) Date: 2021-07-28 Impact factor: 4.599
Authors: Eija Bergroth; Matilda Aakula; Varpu Elenius; Sami Remes; Eija Piippo-Savolainen; Matti Korppi; Pedro A Piedra; Yury A Bochkov; James E Gern; Carlos A Camargo; Tuomas Jartti Journal: J Allergy Clin Immunol Pract Date: 2019-09-11